What is Specialty PharmaSource?
Founded in 2016 and headquartered in New Jersey, Specialty PharmaSource operates as a critical partner for organizations engaged in complex drug development. The company specializes in the procurement of Comparator Drug Products and Reference Listed Drugs, which are essential for conducting rigorous bioequivalence studies and clinical trials. Beyond sourcing, the firm provides comprehensive services including the manufacturing of sterile injectables and high-level regulatory consulting. By bridging the gap between U.S.-based regulatory standards and global supply chain logistics, Specialty PharmaSource mitigates risks associated with drug shortages and ensures that clinical sponsors maintain project timelines with high-quality, compliant materials.
How much funding has Specialty PharmaSource raised?
Specialty PharmaSource has raised a total of $49K across 1 funding round:
Debt
$49K
Debt (2021): $49K with participation from PPP
Key Investors in Specialty PharmaSource
PPP
Public-Private Partnership
What's next for Specialty PharmaSource?
With the infusion of this latest capital, Specialty PharmaSource is expected to scale its infrastructure to meet the rising demand for specialized clinical supplies. The strategic focus will likely shift toward enhancing its global distribution network and expanding its sterile injectable manufacturing capacity. As the pharmaceutical industry faces increasing pressure to streamline drug development cycles, the company's ability to provide reliable, compliant, and secure sourcing solutions will be a key driver of its long-term growth. Future initiatives will likely prioritize the integration of advanced supply chain technologies to further optimize regulatory compliance and operational efficiency for its international client base.
See full Specialty PharmaSource company page
